Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 20, 2024 - Issue 1
Submit an article Journal homepage
644
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus

Trends in the administration of COVID-19 vaccines with other vaccines in the United States reported to V-safe during December 14, 2020—May 19, 2023

Casey E. Parkera Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA;b ORISE Health Studies Program, Oak Ridge Associated Universities, Oak Ridge, TN, USAView further author information
,
Anne M. Hausea Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USACorrespondence[email protected]
View further author information
,
Paige Marqueza Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USAView further author information
,
Bicheng Zhanga Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USAView further author information
,
Tanya R. Myersa Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USAView further author information
&
David K. Shaya Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USAView further author information
Article: 2361946 | Received 30 Apr 2024, Accepted 27 May 2024, Published online: 07 Jun 2024

References

  • Mbaeyi S. Use of Pfizer-BioNTech COVID-19 Vaccine: clinical Considerations. ACIP COVID-19 Vaccines Work Group. December 19, 2020. Atlanta, GA: The Advisory Committee on Immunization Practices Meeting.
  • Advisory Committee on Immunization Practices. Meeting of the Advisory Committee on Immunization Practices (ACIP), MAY 12, 2021. Meeting Minutes. https://stacks.cdc.gov/view/cdc/114614.
  • Mbaeyi S, Oliver SE, Collins JP, Godfrey M, Goswami ND, Hadler SC, Jones J, Moline H, Moulia D, Reddy S, et al. The advisory committee on immunization practices’ interim recommendations for additional primary and booster doses of COVID-19 vaccines — United States, 2021. MMWR Morb Mortal Wkly Rep. 2021 Nov 5;70(44):1545–5. doi:10.15585/mmwr.mm7044e2.
  • Rosenblum HG, Wallace M, Godfrey M, Roper LE, Hall E, Fleming-Dutra KE, Link-Gelles R, Pilishvili T, Williams J, Moulia DL, et al. Interim recommendations from the advisory committee on immunization practices for the use of bivalent booster doses of COVID-19 vaccines — United States, October 2022. MMWR Morb Mortal Wkly Rep. 2022 Nov 11;71(45):1436–41. doi:10.15585/mmwr.mm7145a2.
  • Myers TR, Marquez PL, Gee JM, Hause AM, Panagiotakopoulos L, Zhang B, McCullum I, Licata C, Olson CK, Rahman S, et al. The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC’s COVID-19 pandemic response. Vaccine. 2023 Feb 10;41(7):1310–18. doi:10.1016/j.vaccine.2022.12.031.
  • Centers for Disease Control and Prevention. MMWR weeks. Surveillance case definitions for current and historical conditions. [accessed 2023 June 12]. https://ndc.services.cdc.gov/wp-content/uploads/MMWR_Week_overview.pdf.
  • Centers for Disease Control and Prevention. U.S. Influenza surveillance: purpose and methods. [accessed 2023 June 12]. https://www.cdc.gov/flu/weekly/overview.htm.
  • Centers for Disease Control and Prevention. Weekly National Flu Vaccination Dashboard. Updated April 28, 2023. [accessed 2023 June 12]. https://www.cdc.gov/flu/fluvaxview/dashboard/vaccination-dashboard.html.
  • Kenigsberg TA, Goddard K, Hanson KE, Lewis N, Klein N, Irving SA, Naleway AL, Crane B, Kauffman TL, Xu S, et al. Simultaneous administration of mRNA COVID-19 bivalent booster and influenza vaccines. Vaccine. 2023 Sep 7;41(39):5678–82. doi:10.1016/j.vaccine.2023.08.023.
  • Grohskopf LA, Blanton LH, Ferdinands JM, Chung JR, Broder KR, Talbot HK. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices — United States, 2023–24 influenza season. MMWR Recomm Rep. 2023 Aug 25;72(2):1–28. doi:10.15585/mmwr.rr7202a1.
  • Centers for Disease Control and Prevention. Timing and spacing of immunobiologics: general best practice guidelines for immunization. [accessed 2023 Jul 3]. https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html.
  • Moro PL, Zhang B, Ennulat C, Harris M, McVey R, Woody G, Marquez P, McNeil MM, Su JR. Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021–June 30, 2022. Vaccine. 2023 Mar 10;41(11):1859–63. doi:10.1016/j.vaccine.2022.12.069.
  • Hause AM, Zhang B, Yue X, Marquez P, Myers TR, Parker C, Gee J, Su J, Shimabukuro TT, Shay DK, et al. Reactogenicity of simultaneous COVID-19 mRNA booster and influenza vaccination in the US. JAMA Netw Open. 2022 Jul 1;5(7):e2222241. doi:10.1001/jamanetworkopen.2022.22241.
  • Kenigsberg TA, Hanson KE, Klein NP, Zerbo O, Goddard K, Xu S, Yih WK, Irving SA, Hurley LP, Glanz JM, et al. Safety of simultaneous vaccination with COVID-19 vaccines in the vaccine safety datalink. Vaccine. 2023 Jul 19;41(32):4658–65. doi:10.1016/j.vaccine.2023.06.042.
  • Janssen C, Mosnier A, Gavazzi G, Combadière B, Crépey P, Gaillat J, Launay O, Botelho-Nevers E. Coadministration of seasonal influenza and COVID-19 vaccines: a systematic review of clinical studies. Hum Vaccin Immunother. 2022 Nov 30;18(6):2131166. doi:10.1080/21645515.2022.2131166.
  • Centers for Disease Control and Prevention. COVID-19 vaccination coverage and vaccine confidence. [accessed 2023 June 12]. https://www.cdc.gov/vaccines/imz-managers/coverage/covidvaxview/interactive.html.
  • Centers for Disease Control and Prevention. Child and adolescent immunization schedule by age. [accessed 2023 Jul 10]. https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html.
  • Bonanni P, Steffen R, Schelling J, Balaisyte-Jazone L, Posiuniene I, Zatoński M, Van Damme P. Vaccine co-administration in adults: An effective way to improve vaccination coverage. Hum Vaccin Immunother. 2023 Dec 31;19(1):2195786. doi:10.1080/21645515.2023.2195786.
  • Centers for Disease Control and Prevention. Results from Omnibus Surveys on Vaccination Receipt, Intent, and Knowledge, Attitudes, Beliefs, and Behaviors October 2023. 2023. https://www.cdc.gov/vaccines/ed/downloads/omnibus-vaccination-surveys-2023-10.pdf.
  • Melgar M, Britton A, Roper LE, Talbot HK, Long SS, Kotton CN, Havers FP. Use of respiratory syncytial virus vaccines in older adults: recommendations of the advisory committee on immunization practices — United States, 2023. MMWR Morb Mortal Wkly Rep. 2023 Jul 21;72(29):793–801. doi:10.15585/mmwr.mm7229a4.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.